內皮細胞培養(yǎng)基是一種低血清內皮細胞完全培養(yǎng)基，適合血管內皮細胞和永生化的內皮細胞株。

內皮細胞培養(yǎng)基經10種人各部位的內皮細胞的測試和優(yōu)化，經無菌，無支原體，無內毒素檢測，添加肝素，內皮生長因子，胰島素，抗氧化劑，皮質醇等組分，為了實現(xiàn)細胞的正常的新陳代謝過程，培養(yǎng)基盡量減少生長刺激的因子組分。

其中

P1001-NG是無糖的培養(yǎng)基系列，

P1001-NL是無谷氨酰胺的培養(yǎng)基系列，

P1001-M是小鼠內皮培養(yǎng)系列，

P1001-R是大鼠內皮系列

培養(yǎng)基配方：

基礎培養(yǎng)基：500ml(P1000)，細胞生長因子（ECGS）：5ml (P1002)，胎牛血清：25ml（SD0200），

G/A：5ml(SD0038）

培養(yǎng)基優(yōu)勢：

1.BBB實驗首選共培養(yǎng)培養(yǎng)基，適用于大部分血管內皮細胞的培養(yǎng)，擴增和傳代，還分大小鼠和人源的哦。

2.細化分類，分為人源，大鼠源，小鼠源內皮培養(yǎng)系列。

3.大罐過濾灌裝，采用人工稱量后再進行自動稱量，保持各化學組分均衡反應與充分結合，保質期一年，避免存放過久氨基酸降解及激素變性。

4.采用小分子化合物抑制雜細胞生長，添加促內皮生長因子讓內皮細胞生長。

5.經60多種內皮細胞驗證生長速度；可平替進口品牌。

6.低血清組分減少血清在細胞內的干擾。

7.套裝發(fā)貨，配制簡單，使用方便。

備注：100ml瓶裝無套件，為整瓶配制。

聲明：產品僅科研使用。

1. PMID: 35369032  nternational Journal of Nanomedicine 2022:17 1397–1408  Combined Prussian Blue Nanozyme Carriers Improve Photodynamic Therapy and Effective Interruption of Tumor Metastasis

2. Pleiotropic Immunomodulatory Functions of Radioactive Inactivated Bacterial Vectors for Enhanced Cancer Radio-immunotherapy.ACS Nano 2022, 16, 7, 11325–11337 

https://doi.org/10.1021/acsnano.2c04982

3. Interleukin-19 Promotes Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy Investigative Ophthalmology & Visual Science July 2022, Vol.63, 9

https://pubmed.ncbi.nlm.nih.gov/35816041

4. himpanzee adenovirus-mediated multiple gene therapy for age-related macular degeneration.Published:September 15, 2023

https://doi.org/10.1016/j.isci.2023.10793

5. Potential role of nitrogen in spore dispersal and infection of Paraphysoderma sedebokerense, a fungal parasite of Haematococcus pluvialis Received 2 April 2021 

https://doi.org/10.1016/j.algal.2021.102552

6. Injectable Living Probiotic Dressing Built by Droplet-Based Microfluidics and Photo-Cross-Linking to Prevent Pathogenic Infection and Promote Wound Repair.16 October 2023 

https://doi.org/10.1002/adhm.202302423

7. Single?cell transcriptomics reveal the crosstalk between plate- 1 let-associated TRAF4high endothelial cell subpopulation and 2 tumor microenvironment in colorectal cancer 

https://doi.org/10.21203/rs.3.rs-4506500/v1

8. Chimpanzee adenovirus-mediated multiple gene therapy for age-related macular degeneration

https://doi.org/10.1016/j.isci.2023.107939

9. LncRNA-MM2P regulates retinal neovascularization through M2 macrophage polarization author links open overlay 

https://doi.org/10.1016/j.exer.2024.110072

10. Haixiang Zhou, Bingyan Li, Zicong Wang , Yuting Cai , Shigeo Yoshida , Yedi Zhou, Yun Li,HO-1-mediated ferroptosis regulates retinal neovascularization via the COX2/VEGFA axis

https://doi.org/10.1016/j.freeradbiomed.2024.11.017

11. Shen, W., Han, G., Yu, L., Yang, S., Li, X., Zhang, W., & Pei, P. (2022). Combined Prussian Blue Nanozyme Carriers Improve Photodynamic Therapy and Effective Interruption of Tumor Metastasis. International Journal of Nanomedicine, 17, 1397–1408

https://doi.org/10.2147/IJN.S359156

12. Exploring PU.1 as a Therapeutic Target to Mitigate Oxidative Stress and Inflammation in Peritoneal Dialysis-Induced Peritoneal Fibrosis

https://doi.org/10.1096/fj.202500305RR

13. A bilayer dissolving microneedle for Co-delivery of Bletilla striata polysaccharide and resveratrol to promote synergistic wound healing

https://doi.org/10.1016/j.ijbiomac.2025.149724

14. Biomimetic nanoparticles facilitate homologous targeting and radiosensitivity in glioblastoma cells

https://doi.org/10.1016/j.mtnano.2025.100676

15. M2 Macrophage-Derived Migrasomes Mediate Ischaemia-Induced Retinal Neovascularization by Targeting TREM2,First published: 31 October 2025

https://doi.org/10.1002/jev2.70180

16.X.Xu, L.Guan, B.Tayier, et al. “Preliminary Study of a Ninj1-Loaded Bimodal Ultrasound/NIR Fluorescence Targeted Molecular Probe for Diagnosing Early-Stage Inflammation in Coronary Microvascular Dysfunction.” Advanced Healthcare Materials15, no. 15 (2026): e03403. 

https://doi.org/10.1002/adhm.202503403